đź“‹ FDA Reference
philips solarium hp 3134
Philips Int'L
Summary: The Philips Solarium HP 3134 is a medical device used for therapeutic purposes, primarily in dermatology and cosmetic treatments. It is typically used by dermatologists and cosmetic specialists.
FDA Clearance Information
Pathway
510K
Number
K852348 ↗
Decision Date
June 27, 1985
Product Code
FTC
Device Class
Class 2
Evidence
419 studies
The Philips Solarium HP 3134 was cleared through the FDA 510k pathway on June 27, 1985. Manufactured by Philips Int'L, it is classified as a Class 2 device under product code FTC.
What It Is
The Philips Solarium HP 3134 is a therapeutic device designed to emit controlled ultraviolet light for medical and cosmetic treatments. It is commonly used in dermatology to manage skin conditions such as psoriasis, eczema, and vitiligo. The device operates by delivering specific wavelengths of light to the skin, which can help reduce inflammation and promote healing.
Clinical Applications
Clinically, the Philips Solarium HP 3134 is used in dermatology clinics and cosmetic treatment centers. It is particularly useful for patients with chronic skin conditions requiring phototherapy. Dermatologists and cosmetic specialists use this device to provide targeted light therapy, which can be an effective adjunct to topical or systemic treatments. It is suitable for a wide range of patients, including those with light-sensitive skin disorders.
Indications for Use
The FDA-cleared indications for the Philips Solarium HP 3134 involve its use in phototherapy for skin conditions. This includes treating patients with psoriasis, eczema, and other dermatological conditions that benefit from controlled UV exposure.
Practical Considerations
When using the Philips Solarium HP 3134, clinicians should consider the appropriate distance and duration of exposure to achieve optimal therapeutic outcomes. It is important to ensure compatibility with the patient's skin type and condition. Protective eyewear should be used to prevent UV damage to the eyes during treatment.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Philips Solarium HP 3134 used for?
The Philips Solarium HP 3134 is used for phototherapy in the treatment of skin conditions like psoriasis and eczema.
What specialties typically use this device?
This device is typically used by dermatologists and cosmetic specialists.
What are the FDA-cleared indications?
The device is indicated for phototherapy in treating dermatological conditions such as psoriasis and eczema.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.